Global Virtual Clinical Trials Market Industry Analysis and Forecast Report Released
Reportlinker.com has announced the release of the report "Global Virtual Clinical Trials Market By Study Type, By Indication, By Region, Industry Analysis and Forecast, 2020 – 2026."
The market is significantly driven by growth in R&D activities, the growing digitization in healthcare, and the adoption of telehealth. Virtual Clinical Trials or remote/decentralized trails are a relatively new but still underused technique of carrying out clinical research taking complete benefit of technologies like apps, online social interaction platforms, and electronic monitoring tools. Advances in technology, collaborations between clinical research companies, biotechnology companies, and pharmaceutical and support initiatives from governments, are expected to boost the market. The market’s size is expected to reach $10 billion by 2026, rising at a market growth of 6. 5% CAGR during the forecast period.
For more of report’s analysis, click here.
Semaglutide Significantly Improves Steatohepatitis, Fibrosis in Phase III MASH Trial
May 2nd 2025Interim results from the Phase III ESSENCE trial published in The New England Journal of Medicine show once-weekly semaglutide improved liver histology, metabolic markers, and weight loss in patients with biopsy-confirmed metabolic dysfunction–associated steatohepatitis and stage 2 or 3 fibrosis.
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
